Quick Answer
Aldeyra Therapeutics, Inc. reported Earnings Per Share Diluted of $0.56 (loss) per share for the year ending 2025.
- Aldeyra Therapeutics, Inc. showed an increase of +40.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Aldeyra Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2013 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2013 to 2025), Aldeyra Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 96.8%.
- Historical annual values: Fiscal year 2025: $0.56 (loss) per share | Fiscal year 2024: $0.94 (loss) per share | Fiscal year 2023: $0.64 (loss) per share | Fiscal year 2022: $1.06 (loss) per share | Fiscal year 2021: $1.07 (loss) per share | Fiscal year 2015: $1.40 (loss) per share | Fiscal year 2014: $3.09 (loss) per share | Fiscal year 2013: $17.61 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: